Business · 11/03/1994Updated: 10/15/2026 · 1 min read
Lilly Research Laboratories, et al.; Withdrawal of Approval of 57 Abbreviated Antibiotic Drug Applications
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 57 abbreviated antibiotic drug applications after receiving written notifications from their holders that the drug products were no longer marketed.
Original source language: Federal Register — Health and Human ServicesOpen original release →